Cibus (NASDAQ:CBUS) Upgraded to Strong-Buy by Canaccord Genuity Group

Cibus (NASDAQ:CBUS) was upgraded by analysts at Canaccord Genuity Group to a “strong-buy” rating in a research report issued on Friday, Zacks.com reports.

CBUS has been the subject of several other reports. HC Wainwright reiterated a “buy” rating and issued a $25.00 price target on shares of Cibus in a research note on Friday, May 10th. Canaccord Genuity Group reiterated a “buy” rating and issued a $22.00 price target on shares of Cibus in a research note on Friday.

Cibus Trading Down 2.0 %

Cibus stock opened at $9.40 on Friday. Cibus has a 12 month low of $7.41 and a 12 month high of $23.18. The stock’s 50 day moving average is $11.74 and its 200-day moving average is $15.91. The company has a market capitalization of $202.57 million, a price-to-earnings ratio of -0.51 and a beta of 1.91.

Cibus (NASDAQ:CBUS) last posted its earnings results on Thursday, May 9th. The company reported ($1.12) EPS for the quarter, missing the consensus estimate of ($1.01) by ($0.11). The firm had revenue of $0.55 million during the quarter, compared to analyst estimates of $0.40 million. Cibus had a negative net margin of 12,313.28% and a negative return on equity of 23.33%. During the same period in the previous year, the company posted ($5.45) EPS. As a group, equities research analysts predict that Cibus will post -3.22 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Cibus

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Citigroup Inc. bought a new position in shares of Cibus in the 3rd quarter valued at $199,000. Blue Trust Inc. bought a new position in shares of Cibus in the 4th quarter valued at $301,000. Indie Asset Partners LLC lifted its stake in shares of Cibus by 30.1% in the 4th quarter. Indie Asset Partners LLC now owns 16,929 shares of the company’s stock valued at $332,000 after acquiring an additional 3,921 shares during the last quarter. Cerity Partners LLC bought a new position in shares of Cibus in the 4th quarter valued at $323,000. Finally, Gladius Capital Management LP bought a new position in shares of Cibus in the 4th quarter valued at $56,000. 33.81% of the stock is currently owned by institutional investors.

About Cibus

Cibus, Inc, a agricultural biotechnology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases.